Glycogen synthase kinase-3 plays a central role in mediating glucocorticoid-induced apoptosis

Molecular Endocrinology

Volumn 24, Issue 6, 2010, Pages 1136-1150

  Spokoini, Rachel ^a   Kfir Erenfeld, Shlomit ^a   Yefenof, Eitan ^a   Sionov, Ronit Vogt ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BIM PROTEIN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; NOTCH1 RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HUMAN CELL; LYMPHOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SCREENING; SENSITIVITY ANALYSIS; T CELL LEUKEMIA;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL LINE; DEXAMETHASONE; DRUG RESISTANCE, NEOPLASM; ENZYME ACTIVATION; GLUCOCORTICOIDS; GLYCOGEN SYNTHASE KINASE 3; HUMANS; LIGANDS; MEMBRANE PROTEINS; MICE; MODELS, BIOLOGICAL; PROTEIN BINDING; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, GLUCOCORTICOID; RECEPTORS, NOTCH;

EID: 77954823170     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2009-0466     Document Type: Article

References (87)

1. Sionov RV, Kfir S, Zafrir E, Cohen O, Zilberman Y, Yefenof E 2006 Glucocorticoid-induced apoptosis revisited: a novel role for glucocorticoid receptor translocation to the mitochondria. Cell Cycle 5:1017-1026
2. Sionov RV, Spokoini R, Kfir-Erenfeld S, Cohen O, Yefenof E 2008 Mechanisms regulating the susceptibility of hematopoietic malignancies to glucocorticoid-induced apoptosis. Adv Cancer Res 101:127-248
3. Wang Z, Malone MH, He H, McColl KS, Distelhorst CW 2003 Microarray analysis uncovers the induction of the proapoptotic BH3-only protein Bim in multiple models of glucocorticoid-induced apoptosis. J Biol Chem 278:23861-23867
4. Puthalakath H, Strasser A 2002 Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ 9:505-512
5. Haller J, Mikics E, Makara GB 2008 The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings. Front Neuroendocrinol 29:273-291
6. Song IH, Buttgereit F 2006 Non-genomic glucocorticoid effects to provide the basis for new drug developments. Mol Cell Endocrinol 246:142-146
7. Distelhorst CW 2002 Recent insights into the mechanism of glucocorticosteroid-induced apoptosis. Cell Death Differ 9:6-19
8. Tome ME, Baker AF, Powis G, Payne CM, Briehl MM 2001 Catalase- overexpressing thymocytes are resistant to glucocorticoid-induced apoptosis and exhibit increased net tumor growth. Cancer Res 61:2766-2773
9. Tonomura N, McLaughlin K, Grimm L, Goldsby RA, Osborne BA 2003 Glucocorticoid-induced apoptosis of thymocytes: requirement of proteasome-dependent mitochondrial activity. J Immunol 170:2469-2478
10. Zamzami N, Marchetti P, Castedo M, Decaudin D, Macho A, Hirsch T, Susin SA, Petit PX, Mignotte B, Kroemer G 1995 Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J Exp Med 182:367-377
11. Wang D, Müller N, McPherson KG, Reichardt HM 2006 Glucocorticoids engage different signal transduction pathways to induce apoptosis in thymocytes and mature T cells. J Immunol 176:1695-1702
12. Cifone MG, Migliorati G, Parroni R, Marchetti C, Millimaggi D, Santoni A, Riccardi C 1999 Dexamethasone-induced thymocyte apoptosis: apoptotic signal involves the sequential activation of phosphoinositide-specific phospholipase C, acidic sphingomyelinase, and caspases. Blood 93:2282-2296
13. Sionov RV, Cohen O, Kfir S, Zilberman Y, Yefenof E 2006 Role of mitochondrial glucocorticoid receptor in glucocorticoid-induced apoptosis. J Exp Med 203:189-201
14. Ismaili N, Garabedian MJ 2004 Modulation of glucocorticoid receptor function via phosphorylation. Ann NY Acad Sci 1024:86-101
15. Chen W, Dang T, Blind RD, Wang Z, Cavasotto CN, Hittelman AB, Rogatsky I, Logan SK, Garabedian MJ 2008 Glucocorticoid receptor phosphorylation differentially affects target gene expression. Mol Endocrinol 22:1754-1766
16. Herr I, Gassler N, Friess H, Büchler MW 2007 Regulation of differential pro- and anti-apoptotic signaling by glucocorticoids. Apoptosis 12:271-291
17. Kassel O, Sancono A, Krätzschmar J, Kreft B, Stassen M, Cato AC 2001 Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1. EMBO J 20:7108-7116
18. Tessier M, Woodgett JR 2006 Serum and glucocorticoid-regulated protein kinases: variations on a theme. J Cell Biochem 98:1391-1407
19. Abraham SM, Clark AR 2006 Dual-specificity phosphatase 1: a critical regulator of innate immune responses. Biochem Soc Trans 34:1018-1023
20. Bruna A, Nicolàs M, Muñoz A, Kyriakis JM, Caelles C 2003 Glucocorticoid receptor-JNK interaction mediates inhibition of the JNK pathway by glucocorticoids. EMBO J 22:6035-6044
21. Davies L, Karthikeyan N, Lynch JT, Sial EA, Gkourtsa A, Demonacos C, Krstic-Demonacos M 2008 Crosstalk of signaling pathways in the regulation of the glucocorticoid receptor function. Mol Endocrinol 22:1331-1344
22. Galliher-Beckley AJ, Williams JG, Collins JB, Cidlowski JA 2008 Glycogen synthase kinase 3β-mediated serine phosphorylation of the human glucocorticoid receptor redirects gene expression profiles. Mol Cell Biol 28:7309-7322
23. Kino T, Ichijo T, Amin ND, Kesavapany S, Wang Y, Kim N, Rao S, Player A, Zheng YL, Garabedian MJ, Kawasaki E, Pant HC, Chrousos GP 2007 Cyclin-dependent kinase 5 differentially regulates the transcriptional activity of the glucocorticoid receptor through phosphorylation: clinical implications for the nervous system response to glucocorticoids and stress. Mol Endocrinol 21:1552-1568
24. Krstic MD, Rogatsky I, Yamamoto KR, Garabedian MJ 1997 Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor. Mol Cell Biol 17:3947-3954
25. Rogatsky I, Waase CL, Garabedian MJ 1998 Phosphorylation and inhibition of rat glucocorticoid receptor transcriptional activation by glycogen synthase kinase-3 (GSK-3). Species-specific differences between human and rat glucocorticoid receptor signaling as revealed through GSK-3 phosphorylation. J Biol Chem 273:14315-14321
26. Hideshima T, Nakamura N, Chauhan D, Anderson KC 2001 Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma. Oncogene 20:5991-6000
27. Miller AL, Garza AS, Johnson BH, Thompson EB 2007 Pathway interactions between MAPKs, mTOR, PKA, and the glucocorticoid receptor in lymphoid cells. Cancer Cell Int 7:3
28. Nuutinen U, Postila V, Mättö M, Eeva J, Ropponen A, Eray M, Riikonen P, Pelkonen J 2006 Inhibition of PI3-kinase-Akt pathway enhances dexamethasone-induced apoptosis in a human follicular lymphoma cell line. Exp Cell Res 312:322-330
29. Sade H, Sarin A 2003 IL-7 inhibits dexamethasone-induced apoptosis via Akt/PKB in mature, peripheral T cells. Eur J Immunol 33:913-919
30. + T cells. J Clin Invest 113:619-627
31. Wei G, Twomey D, Lamb J, Schlis K, Agarwal J, Stam RW, Opferman JT, Sallan SE, den Boer ML, Pieters R, Golub TR, Armstrong SA 2006 Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance. Cancer Cell 10:331-342
32. Kfir S, Sionov RV, Zafrir E, Zilberman Y, Yefenof E 2007 Staurosporine sensitizes T lymphoma cells to glucocorticoid-induced apoptosis: Role of Nur77 and Bcl-2. Cell Cycle 6:3086-3096
33. Trudel S, Li ZH, Wei E, Wiesmann M, Chang H, Chen C, Reece D, Heise C, Stewart AK 2005 CHIR-258, a novel, multitargeted tyrosine kinase inhibitor for the potential treatment of t(4;14) multiple myeloma. Blood 105:2941-2948
34. Miller AL, Webb MS, Copik AJ, Wang Y, Johnson BH, Kumar R, Thompson EB 2005 p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and sitespecific phosphorylation of the human glucocorticoid receptor at serine 211. Mol Endocrinol 19:1569-1583
35. Lu J, Quearry B, Harada H 2006 p38-MAP kinase activation followed by Bim induction is essential for glucocorticoid-induced apoptosis in lymphoblastic leukemia cells. FEBS Lett 580:3539-3544
36. Tanaka T, Okabe T, Gondo S, Fukuda M, Yamamoto M, Umemura T, Tani K, Nomura M, Goto K, Yanase T, Nawata H 2006 Modification of glucocorticoid sensitivity by MAP kinase signaling pathways in glucocorticoid-induced T-cell apoptosis. Exp Hematol 34:1542-1552
37. Yoshino T, Kishi H, Nagata T, Tsukada K, Saito S, Muraguchi A 2001 Differential involvement of p38 MAP kinase pathway and Bax translocation in the mitochondria-mediated cell death in TCR- and dexamethasone-stimulated thymocytes. Eur J Immunol 31:2702-2708
38. Chauhan D, Pandey P, Ogata A, Teoh G, Treon S, Urashima M, Kharbanda S, Anderson KC 1997 Dexamethasone induces apoptosis of multiple myeloma cells in a JNK/SAP kinase independent mechanism. Oncogene 15:837-843
39. Druilhe A, Létuvé S, Pretolani M 2003 Glucocorticoid- induced apoptosis in human eosinophils: mechanisms of action. Apoptosis 8:481-495
40. Granés F, Roig MB, Brady HJ, Gil-Gómez G 2004 Cdk2 activation acts upstream of the mitochondrion during glucocorticoid induced thymocyte apoptosis. Eur J Immunol 34:2781-2790
41. Gil-Gómez G, Berns A, Brady HJ 1998 A link between cell cycle and cell death: Bax and Bcl-2 modulate Cdk2 activation during thymocyte apoptosis. EMBO J 17:7209-7218
42. Berthet C, Rodriguez-Galan MC, Hodge DL, Gooya J, Pascal V, Young HA, Keller J, Bosselut R, Kaldis P 2007 Hematopoiesis and thymic apoptosis are not affected by the loss of Cdk2. Mol Cell Biol 27:5079-5089
43. Marchetti MC, Di Marco B, Cifone G, Migliorati G, Riccardi C 2003 Dexamethasone-induced apoptosis of thymocytes: role of glucocorticoid receptor-associated Src kinase and caspase-8 activation. Blood 101:585-593
44. Chauhan D, Hideshima T, Pandey P, Treon S, Teoh G, Raje N, Rosen S, Krett N, Husson H, Avraham S, Kharbanda S, Anderson KC 1999 RAFTK/PYK2-dependent and -independent apoptosis in multiple myeloma cells. Oncogene 18:6733-6740
45. Werlen G, Hausmann B, Naeher D, Palmer E 2003 Signaling life and death in the thymus: timing is everything. Science 299:1859-1863
46. Golsteyn RM 2005 Cdk1 and Cdk2 complexes (cyclin dependent kinases) in apoptosis: a role beyond the cell cycle. Cancer Lett 217:129-138
47. Pap M, Cooper GM 1998 Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway. J Biol Chem 273:19929-19932
48. Beurel E, Jope RS 2006 The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways. Prog Neurobiol 79:173-189
49. Abrams MT, Robertson NM, Yoon K, Wickstrom E 2004 Inhibition of glucocorticoid-induced apoptosis by targeting the major splice variants of BIM mRNA with small interfering RNA and short hairpin RNA. J Biol Chem 279:55809-55817
50. Bouillet P, Metcalf D, Huang DC, Tarlinton DM, Kay TW, Köntgen F, Adams JM, Strasser A 1999 Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 286:1735-1738
51. Kockeritz L, Doble B, Patel S, Woodgett JR 2006 Glycogen synthase kinase-3-an overview of an over-achieving protein kinase. Curr Drug Targets 7:1377-1388
52. Maddika S, Ande SR, Panigrahi S, Paranjothy T, Weglarczyk K, Zuse A, Eshraghi M, Manda KD, Wiechec E, Los M 2007 Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy. Drug Resist Updat 10:13-29
53. Deftos ML, He YW, Ojala EW, Bevan MJ 1998 Correlating notch signaling with thymocyte maturation. Immunity 9:777-786
54. Sharma VM, Draheim KM, Kelliher MA 2007 The Notch1/c-Myc pathway in T cell leukemia. Cell Cycle 6:927-930
55. Sade H, Krishna S, Sarin A 2004 The anti-apoptotic effect of Notch-1 requires p56lck-dependent, Akt/PKB-mediated signaling in T cells. J Biol Chem 279:2937-2944
56. Maurer U, Charvet C, Wagman AS, Dejardin E, Green DR 2006 Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1. Mol Cell 21:749-760
57. Almawi WY, Melemedjian OK, Jaoude MM 2004 On the link between Bcl-2 family proteins and glucocorticoid-induced apoptosis. J Leukoc Biol 76:7-14
58. Zhang L, Insel PA 2004 The pro-apoptotic protein Bim is a convergence point for cAMP/protein kinase A- and glucocorticoid-promoted apoptosis of lymphoid cells. J Biol Chem 279:20858-20865
59. Cai B, Chang SH, Becker EB, Bonni A, Xia Z 2006 p38 MAP kinase mediates apoptosis through phosphorylation of BimEL at Ser-65. J Biol Chem 281:25215-25222
60. De Chiara G, Marcocci ME, Torcia M, Lucibello M, Rosini P, Bonini P, Higashimoto Y, Damonte G, Armirotti A, Amodei S, Palamara AT, Russo T, Garaci E, Cozzolino F 2006 Bcl-2 phosphorylation by p38 MAPK: identification of target sites and biological consequences. J Biol Chem 281:21353-21361
61. Greenstein S, Ghias K, Krett NL, Rosen ST 2002 Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies. Clin Cancer Res 8:1681-1694
62. Hartigan JA, Johnson GV 1999 Transient increases in intracellular calcium result in prolonged site-selective increases in Tau phosphorylation through a glycogen synthase kinase 3β-dependent pathway. J Biol Chem 274:21395-21401
63. Mora A, Sabio G, Risco AM, Cuenda A, Alonso JC, Soler G, Centeno F 2002 Lithium blocks the PKB and GSK3 dephosphorylation induced by ceramide through protein phosphatase-2A. Cell Signal 14:557-562
64. Linseman DA, Butts BD, Precht TA, Phelps RA, Le SS, Laessig TA, Bouchard RJ, Florez-McClure ML, Heidenreich KA 2004 Glycogen synthase kinase-3β phosphorylates Bax and promotes its mitochondrial localization during neuronal apoptosis. J Neurosci 24:9993-10002
65. Pastorino JG, Hoek JB, Shulga N 2005 Activation of glycogen synthase kinase 3β disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity. Cancer Res 65:10545-10554
66. Sade H, Khandre NS, Mathew MK, Sarin A 2004 The mitochondrial phase of the glucocorticoid-induced apoptotic response in thymocytes comprises sequential activation of adenine nucleotide transporter (ANT)-independent and ANT-dependent events. Eur J Immunol 34:119-125
67. Pastorino JG, Shulga N, Hoek JB 2002 Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. J Biol Chem 277:7610-7618
68. Tome ME, Lutz NW, Briehl MM 2004 Overexpression of catalase or Bcl-2 alters glucose and energy metabolism concomitant with dexamethasone resistance. Biochim Biophys Acta 1693:57-72
69. Pear WS, Aster JC 2004 T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling. Curr Opin Hematol 11:426-433
70. McKenzie G, Ward G, Stallwood Y, Briend E, Papadia S, Lennard A, Turner M, Champion B, Hardingham GE 2006 Cellular Notch responsiveness is defined by phosphoinositide 3-kinase-dependent signals. BMC Cell Biol 7:10
71. Espinosa L, Inglés-Esteve J, Aguilera C, Bigas A 2003 Phosphorylation by glycogen synthase kinase-3 β down-regulates Notch activity, a link for Notch and Wnt pathways. J Biol Chem 278:32227-32235
72. Breit S, Stanulla M, Flohr T, Schrappe M, Ludwig WD, Tolle G, Happich M, Muckenthaler MU, Kulozik AE 2006 Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia. Blood 108:1151-1157
73. Strömberg T, Dimberg A, Hammarberg A, Carlson K, Osterborg A, Nilsson K, Jernberg-Wiklund H 2004 Rapamycin sensitizes multiple myeloma cells to apoptosis induced by dexamethasone. Blood 103:3138-3147
74. Yan H, Frost P, Shi Y, Hoang B, Sharma S, Fisher M, Gera J, Lichtenstein A 2006 Mechanism by which mammalian target of rapamycin inhibitors sensitize multiple myeloma cells to dexamethasone-induced apoptosis. Cancer Res 66:2305-2313
75. Ding Q, Xia W, Liu JC, Yang JY, Lee DF, Xia J, Bartholomeusz G, Li Y, Pan Y, Li Z, Bargou RC, Qin J, Lai CC, Tsai FJ, Tsai CH, Hung MC 2005 Erk associates with and primes GSK-3β for its inactivation resulting in upregulation of β-catenin. Mol Cell 19: 159-170
76. Deng X, Kornblau SM, Ruvolo PP, May Jr WS 2001 Regulation of Bcl2 phosphorylation and potential significance for leukemic cell chemoresistance. J Natl Cancer Inst Monogr 28:30-37
77. Ewings KE, Wiggins CM, Cook SJ 2007 Bim and the pro-survival Bcl-2 proteins: opposites attract, ERK repels. Cell Cycle 6:2236-2240
78. Ley R, Ewings KE, Hadfield K, Cook SJ 2005 Regulatory phosphorylation of Bim: sorting out the ERK from the JNK. Cell Death Differ 12:1008-1014
79. Liu J, Lin A 2005 Role of JNK activation in apoptosis: a double-edged sword. Cell Res 15:36-42
80. Putcha GV, Le S, Frank S, Besirli CG, Clark K, Chu B, Alix S, Youle RJ, LaMarche A, Maroney AC, Johnson Jr EM 2003 JNK-mediated BIM phosphorylation potentiates BAX-dependent apoptosis. Neuron 38:899-914
81. Leung KT, Li KK, Sun SS, Chan PK, Ooi VE, Chiu LC 2008 Activation of the JNK pathway promotes phosphorylation and degradation of BimEL-a novel mechanism of chemoresistance in T-cell acute lymphoblastic leukemia. Carcinogenesis 29:544-551
82. Yu C, Minemoto Y, Zhang J, Liu J, Tang F, Bui TN, Xiang J, Lin A 2004 JNK suppresses apoptosis via phosphorylation of the proapoptotic Bcl-2 family protein BAD. Mol Cell 13:329-340
83. Shaulian E, Karin M 2002 AP-1 as a regulator of cell life and death. Nat Cell Biol 4:E131-136
84. Hess P, Pihan G, Sawyers CL, Flavell RA, Davis RJ 2002 Survival signaling mediated by c-Jun NH2-terminal kinase in transformed B lymphoblasts. Nat Genet 32:201-205
85. + thymic lymphoma cells. Cell Immunol 227:12-23
86. Jeon SH, Kang MG, Kim YH, Jin YH, Lee C, Chung HY, Kwon H, Park SD, Seong RH 1997 A new mouse gene, SRG3, related to the SWI3 of Saccharomyces cerevisiae, is required for apoptosis induced by glucocorticoids in a thymoma cell line. J Exp Med 185:1827-1836
87. Rathmell JC, Lindsten T, Zong WX, Cinalli RM, Thompson CB 2002 Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis. Nat Immunol 3:932-939